title: Threat to cefixime treatment for gonorrhea.
authors.forename: Shigeaki
authors.initials: S
authors.lastname: Yokoi
authors.forename: Takashi
authors.initials: T
authors.lastname: Deguchi
authors.forename: Tomomi
authors.initials: T
authors.lastname: Ozawa
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Yasuda
authors.forename: Shin-ichi
authors.initials: S
authors.lastname: Ito
authors.forename: Yasuaki
authors.initials: Y
authors.lastname: Kubota
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Tamaki
authors.forename: Shin-ichi
authors.initials: S
authors.lastname: Maeda
mesh_terms: D000328:Adult; D001483:Base Sequence; D020682:Cefixime / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D016521:Electrophoresis, Gel, Pulsed-Field / Q000379:methods; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009344:Neisseria gonorrhoeae / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*
chemical_list: D002443:Ceftriaxone; D020682:Cefixime